Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
Abstract Biologic agents (BA) are able to induce an adaptive immune response in a proportion of exposed patients with the onset of anti-drug antibodies (ADA), which are usually responsible for hypersensitivity reactions (HR). Drug desensitization (DD) for BA allows transient clinical tolerance to th...
Saved in:
Main Authors: | Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, Elena Silvestri, Laura Dies, Emanuele Vivarelli, Enrico Maggi, Andrea Matucci |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e9e52b0688aa4ef3b1e3b6c04744234c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge of healthcare providers in the management of anaphylaxis
by: Sandra Nora González-Díaz, MD, PhD, et al.
Published: (2021) -
Cognitive Systematic Desensitization
by: Malik B. Badri
Published: (2014) -
Anaphylaxis in new European Resuscitation Council guidelines 2021
by: Alihodžić Hajriz
Published: (2021) -
Identification of allergens for food-dependent exercise-induced anaphylaxis to shrimp
by: Shiori Akimoto, et al.
Published: (2021) -
Review of tocilizumab in the treatment of rheumatoid arthritis
by: Yasuaki Okuda
Published: (2008)